Panzyga (human immune globulin intravenous 10% stabilised with glycine) / Octapharma  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Panzyga (human immune globulin intravenous 10% stabilised with glycine) / Octapharma
GAM 10-06, NCT02303093: Non-Interventional Study on the Tolerability and Efficacy of IVIG

Completed
N/A
344
Europe, Canada
Octagam IVIG 5% or 10%, Panzyga
Octapharma
Primary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIG
06/20
06/20

Download Options